BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB

SOL #: CBRND-BAA-22-01Solicitation

Overview

Buyer

DEPT OF DEFENSE

Dept Of The Army

W6QK ACC-APG

ABERDEEN PROVING GROU, MD, 21010-5424, United States

Place of Performance

Frederick, MD

NAICS

Research and Development in the Physical (541715)

PSC

National Defense R&D Services; Department Of Defense Military; Applied Research (AC12)

Set Aside

No set aside specified

Original Source

https://sam.gov/opp/055f41c719a548819dbf838125a05762/view

Timeline

Posted

Jun 11, 2022

Last Updated

Mar 25, 2026

Submission Deadline

Jan 1, 2031, 4:59 AM

Qualification Details

Fit reasons

NAICS alignment with historical contract wins in similar service areas.
Scope strongly matches core technical capabilities and delivery model.

Risks

Past performance thresholds may require one additional teaming partner.
Potential clarification needed on staffing minimums before bid/no-bid.

Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) has issued a Broad Agency Announcement (BAA) for Research and Development in support of JPM Medical and JPL Enabling Biotechnologies. This BAA seeks innovative science to develop medical countermeasures and enabling biotechnologies for CBRN defense. Proposals are accepted from all eligible sources, including educational institutions, non-profit organizations, and private industry. Pre-proposals (white papers) can be submitted at any time while the announcement is active, with a response date of January 1, 2031.

Scope of Work

This BAA focuses on identifying novel solutions and improved methods for:

Developing medical CBRN countermeasures more rapidly and efficiently.
Enabling technologies, life cycle bioinformatics, and improved logistics tracking.
Advanced development efforts are generally limited to Technology Readiness Level (TRL) 4.

Proposals based on data from experiments using specific CBRN warfare agents to demonstrate safety, efficacy, or mode of action are not of interest.

Contract Details

Type: Broad Agency Announcement (Solicitation)
Award Types: Procurement Contracts, Grants, Cooperative Agreements, Technology Investment Agreements (TIAs), and Other Transaction Agreements (OTAs).
Set-Aside: None (Open to all eligible sources).
Response Due: January 1, 2031 (for pre-proposals).
Published: March 24, 2026 (Opportunity), June 11, 2022 (BAA Document).
PSC: AC12 - National Defense R&D Services; Department Of Defense Military; Applied Research.
Place of Performance: Frederick, MD 21702, United States.

Submission & Evaluation

Pre-proposals (white papers) are encouraged and can be submitted at any time.
Full proposals will be solicited via a Request for Full Proposal (RFFP) if a pre-proposal is accepted.
Evaluation Factors: Technical Merit, Military and Program Relevance, Funds Availability, Technology Readiness Level (TRL), Project Objectives, Regulatory Compliance, Support of other U.S. Government requirements, Key Personnel Qualifications, Facilities, Budget/Cost, and Past Performance.
Award decisions are expected within 180 days after full proposal submission.

Additional Notes

Potential Offerors are encouraged to discuss proposal ideas with the JPMO technical contacts listed in Section VII (B) of the BAA. Administrative and general technical questions should be directed to usarmy.detrick.dod-jpeo-cbrnd.mbx.baa@army.mil. The BAA is also available on Grants.gov and the JPEO-CBD website.